文献速递胸部心血管外周血管CT

肺动脉-静脉体积差:急性肺栓塞风险分层的新影像生物标志物

Pulmonary Artery-to-Vein Volume Difference: A New Imaging Biomarker for Risk Stratification in Acute Pulmonary Embolism.
PubMed 文献 · Acad Radiol · 2026-08-25

本研究提出新影像生物标志物肺动脉-静脉体积差(PAVVD),回顾性纳入134例急性肺栓塞患者,用AI软件自动量化PAVVD及传统CTPA参数。结果显示PAVVD识别高/中高危患者的AUC最高(0.89),阴性预测值0.94、阴性似然比0.13,决策曲线分析净获益最优,且与Qanadli评分存在交叉效应。

要点

  • PAVVD识别高/中高危APE的AUC达0.89,优于传统CTPA参数。
  • PAVVD阴性预测值0.94、阴性似然比0.13,漏诊风险低。
  • Qanadli评分<50%时PAVVD更优,≥50%时血栓体积更优。

局限性

  • 回顾性研究设计。
  • 单中心样本量134例,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To propose a new imaging biomarker, the pulmonary artery-to-vein volume difference (PAVVD), and evaluate its efficacy in risk stratification of acute pulmonary embolism (APE) compared with traditional computed tomography pulmonary angiography (CTPA) parameters, as well as the impact of chronic pulmonary disease (CPD).

MATERIALS AND METHODS: This retrospective study included 134 patients with APE (high/intermediate-high risk, n = 46; intermediate-low/low risk, n = 88) from April 2023 to March 2024. A commercial artificial intelligence software was used to automatically quantify PAVVD and traditional CTPA parameters. The performances of different CTPA parameters for APE risk stratification were compared using the area under the curve (AUC), diagnostic metrics (e.g., sensitivity, specificity, negative predictive value [NPV], negative likelihood ratio [NLR]), and decision curve analysis (DCA). Multivariate linear regression was conducted to identify factors influencing PAVVD.

RESULTS: PAVVD exhibited the highest AUC (0.89, 95% CI: 0.83-0.95) for identifying high/intermediate-high risk APE, with the lowest missed diagnosis risk (NPV = 0.94, NLR = 0.13). DCA demonstrated that PAVVD yielded the highest net benefit within the low-to-moderate threshold probability range. A crossover effect was observed between PAVVD and clot volume: PAVVD performed better when the Qanadli score was <50%, while clot volume was superior when the Qanadli score was ≥50%. CPD (β = 35.74, 95% CI: 15.25-56.23; P = 0.001) and log(1+clot volume) (β = 13.34, 95% CI: 8.44-18.25; P < 0.001) were independently correlated with PAVVD.

CONCLUSION: PAVVD is a promising and competitive metric for APE risk stratification. It serves as an important complement to traditional CTPA parameters and has the potential to provide valuable support for emergency triage.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Song X, Ye L, Yan B, et al. Pulmonary Artery-to-Vein Volume Difference: A New Imaging Biomarker for Risk Stratification in Acute Pulmonary Embolism. Acad Radiol. 2026. PMID: 42642319. doi:10.1016/j.acra.2026.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。